Post-transplant donor specific antibody is associated with poor kidney transplant outcomes only when combined with both T-cell–mediated rejection and non-adherence
Kidney International
– Mar 20, 2019
/lp/unpaywall/post-transplant-donor-specific-antibody-is-associated-with-poor-kidney-UNgn518OTQ
References (39)
-
A. Loupy, G. Hill, S. Jordan (2012)
The impact of donor-specific anti-HLA antibodies on late kidney allograft failureNature Reviews Nephrology, 8
-
J. Cooper, J. Gralla, L. Cagle, R. Goldberg, L. Chan, A. Wiseman (2011)
Inferior Kidney Allograft Outcomes in Patients With De Novo Donor-Specific Antibodies Are Due to Acute Rejection EpisodesTransplantation, 91
-
P. Terasaki (2003)
Humoral Theory of TransplantationAmerican Journal of Transplantation, 3
-
Stella Khiew, Jinghui Yang, James Young, Jianjun Chen, Qiang Wang, D. Yin, V. Vu, M. Miller, R. Sciammas, M. Alegre, A. Chong (2017)
CTLA4-Ig in combination with FTY720 promotes allograft survival in sensitized recipients.JCI insight, 2 9
-
A. Loupy, D. Vernerey, C. Tinel, O. Aubert, J. Huyen, M. Rabant, J. Vérine, D. Nochy, J. Empana, F. Martínez, D. Glotz, X. Jouven, C. Legendre, C. Lefaucheur (2015)
Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.Journal of the American Society of Nephrology : JASN, 26 7
-
J. Sellarés, D. Freitas, M. Mengel, J. Reeve, G. Einecke, B. Sis, L. Hidalgo, K. Famulski, A. Matas, P. Halloran (2012)
Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody‐Mediated Rejection and NonadherenceAmerican Journal of Transplantation, 12
-
R. Heilman, Ala Nijim, Yvonne Desmarteau, H. Khamash, M. Pando, Maxwell Smith, H. Chakkera, J. Huskey, R. Valdez, K. Reddy (2014)
De Novo Donor-Specific Human Leukocyte Antigen Antibodies Early After Kidney TransplantationTransplantation, 98
-
P. Halloran, D. Freitas, G. Einecke, K. Famulski, L. Hidalgo, M. Mengel, J. Reeve, J. Sellarés, B. Sis (2010)
An Integrated View of Molecular Changes, Histopathology and Outcomes in Kidney TransplantsAmerican Journal of Transplantation, 10
-
N. Lachmann, P. Terasaki, K. Budde, L. Liefeldt, A. Kahl, P. Reinke, J. Pratschke, B. Rudolph, D. Schmidt, A. Salama, C. Schönemann (2009)
Anti-Human Leukocyte Antigen and Donor-Specific Antibodies Detected by Luminex Posttransplant Serve as Biomarkers for Chronic Rejection of Renal AllograftsTransplantation, 87
-
M. Arias, D. Serón, I. Herrero, D. Rush, C. Wiebe, P. Nickerson, P. Ussetti, E. Rodrigo, M. Cos (2017)
Subclinical Antibody-Mediated RejectionTransplantation, 101
-
N. Valenzuela, E. Reed (2017)
Antibody-mediated rejection across solid organ transplants: manifestations, mechanisms, and therapiesJournal of Clinical Investigation, 127
-
S. Lodhi, Kenneth Lamb, H. Meier‐Kriesche (2011)
Solid Organ Allograft Survival Improvement in the United States: The Long‐Term Does Not Mirror the Dramatic Short‐Term SuccessAmerican Journal of Transplantation, 11
-
C. Schinstock, F. Cosio, W. Cheungpasitporn, Darshana Dadhania, M. Everly, Milagros Samaniego-Picota, Lynn Cornell, M. Stegall (2017)
The Value of Protocol Biopsies to Identify Patients With De Novo Donor‐Specific Antibody at High Risk for Allograft LossAmerican Journal of Transplantation, 17
-
J. Stoves, C. Newstead (2002)
Variability of cyclosporine exposure and its relevance to chronic allograft nephropathy: a case-control study1Transplantation, 74
-
J. Gill, D. Landsberg, O. Johnston, R. Shapiro, A. Magil, V. Wu, K. Tinckam, P. Keown (2010)
Screening for De Novo Anti-Human Leukocyte Antigen Antibodies in Nonsensitized Kidney Transplant Recipients Does Not Predict Acute RejectionTransplantation, 89
-
M. Haas, B. Sis, L. Racusen, K. Solez, D. Glotz, R. Colvin, M. Castro, D. David, E. David‐Neto, S. Bagnasco, L. Cendales, L. Cornell, A. Demetris, C. Drachenberg, C. Farver, A. Farris, I. Gibson, E. Kraus, H. Liapis, A. Loupy, V. Nickeleit, P. Randhawa, E. Rodriguez, D. Rush, R. Smith, Carmela Tan, W. Wallace, M. Mengel (2014)
Banff 2013 Meeting Report: Inclusion of C4d‐Negative Antibody‐Mediated Rejection and Antibody‐Associated Arterial LesionsAmerican Journal of Transplantation, 14
-
M. Everly, J. Everly, L. Arend, P. Brailey, B. Susskind, A. Govil, A. Rike, P. Roy-Chaudhury, G. Mogilishetty, R. Alloway, A. Tevar, E. Woodle (2009)
Reducing De Novo Donor‐Specific Antibody Levels during Acute Rejection Diminishes Renal Allograft LossAmerican Journal of Transplantation, 9
-
O. Aubert, A. Loupy, L. Hidalgo, J. Huyen, S. Higgins, D. Viglietti, X. Jouven, D. Glotz, C. Legendre, C. Lefaucheur, P. Halloran (2017)
Antibody-Mediated Rejection Due to Preexisting versus De Novo Donor-Specific Antibodies in Kidney Allograft Recipients.Journal of the American Society of Nephrology : JASN, 28 6
-
D. Kannabhiran, J. Lee, J. Schwartz, R. Friedlander, M. Aull, T. Muthukumar, S. Campbell, David Epstein, S. Seshan, S. Kapur, V. Sharma, M. Suthanthiran, D. Dadhania (2015)
Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft FailureTransplantation, 99
-
J. DeVos, A. Gaber, L. Teeter, E. Graviss, S. Patel, G. Land, L. Moore, R. Knight (2014)
Intermediate-Term Graft Loss After Renal Transplantation is Associated With Both Donor-Specific Antibody and Acute RejectionTransplantation, 97
-
D. Viglietti, A. Loupy, D. Vernerey, C. Bentlejewski, C. Gosset, O. Aubert, J. Huyen, X. Jouven, C. Legendre, D. Glotz, A. Zeevi, C. Lefaucheur (2017)
Value of Donor-Specific Anti-HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft Loss.Journal of the American Society of Nephrology : JASN, 28 2
-
F. Ginevri, A. Nocera, P. Comoli, Annalisa Innocente, M. Cioni, A. Parodi, I. Fontana, A. Magnasco, A. Nocco, A. Tagliamacco, A. Sementa, P. Ceriolo, L. Ghio, M. Zecca, M. Cardillo, G. Garibotto, G. Ghiggeri, F. Poli (2012)
Posttransplant De Novo Donor‐Specific HLA Antibodies Identify Pediatric Kidney Recipients at Risk for Late Antibody‐Mediated RejectionAmerican Journal of Transplantation, 12
-
P. Lee, P. Terasaki, S. Takemoto, P. Lee, C. Hung, Yi-Lin Chen, Alen Tsai, H. Lei (2002)
All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodiesTransplantation, 74
-
Kenneth Lamb, S. Lodhi, H. Meier‐Kriesche (2011)
Long‐Term Renal Allograft Survival in the United States: A Critical ReappraisalAmerican Journal of Transplantation, 11
-
G. Bartel, H. Regele, M. Wahrmann, N. Huttary, M. Exner, W. Hörl, G. Böhmig (2008)
Posttransplant HLA Alloreactivity in Stable Kidney Transplant Recipients—Incidences and Impact on Long‐Term Allograft OutcomesAmerican Journal of Transplantation, 8
-
L. Borra, J. Roodnat, J. Kal, R. Mathôt, W. Weimar, T. Gelder (2010)
High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 25 8
-
M. Hourmant, A. Cesbron-Gautier, P. Terasaki, K. Mizutani, A. Moreau, Aurélie Meurette, J. Dantal, M. Giral, G. Blancho, D. Cantarovich, G. Karam, G. Folléa, J. Soulillou, J. Bignon (2005)
Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation.Journal of the American Society of Nephrology : JASN, 16 9
-
O. Aubert, M. Bories, C. Suberbielle, R. Snanoudj, D. Anglicheau, D. Anglicheau, M. Rabant, F. Martinez, A. Scemla, C. Legendre, C. Legendre, R. Sberro-Soussan (2014)
Risk of Antibody‐Mediated Rejection in Kidney Transplant Recipients With Anti‐HLA‐C Donor‐Specific AntibodiesAmerican Journal of Transplantation, 14
-
C. Süsal, D. Wettstein, B. Döhler, C. Morath, A. Ruhenstroth, S. Scherer, T. Tran, P. Gombos, P. Schemmer, E. Wagner, T. Fehr, S. Živčić-Ćosić, S. Balen, R. Weimer, A. Slavcev, C. Bösmüller, D. Norman, M. Zeier, G. Opelz (2015)
Association of Kidney Graft Loss With De Novo Produced Donor-Specific and Non-Donor-Specific HLA Antibodies Detected by Single Antigen TestingTransplantation, 99
-
J. Worthington, Susan Martin, Dalia Al-Husseini, P. Dyer, Robert Johnson (2003)
Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome1Transplantation, 75
-
Christopher Wiebe, I. Gibson, T. Blydt-Hansen, M. Karpinski, J. Ho, L. Storsley, A. Goldberg, P. Birk, D. Rush, P. Nickerson (2012)
Evolution and Clinical Pathologic Correlations of De Novo Donor‐Specific HLA Antibody Post Kidney TransplantAmerican Journal of Transplantation, 12
-
N. Shuker, T. Gelder, D. Hesselink (2015)
Intra-patient variability in tacrolimus exposure: causes, consequences for clinical management.Transplantation reviews, 29 2
-
W. Park, M. Griffin, L. Cornell, F. Cosio, M. Stegall (2010)
Fibrosis with inflammation at one year predicts transplant functional decline.Journal of the American Society of Nephrology : JASN, 21 11
-
A. Loupy, C. Lefaucheur, D. Vernerey, C. Prugger, J. Huyen, N. Mooney, C. Suberbielle, V. Frémeaux-Bacchi, A. Méjean, F. Desgrandchamps, D. Anglicheau, D. Nochy, D. Charron, J. Empana, M. Delahousse, C. Legendre, D. Glotz, G. Hill, A. Zeevi, X. Jouven (2013)
Complement-binding anti-HLA antibodies and kidney-allograft survival.The New England journal of medicine, 369 13
-
C. Lefaucheur, C. Suberbielle-Boissel, G. Hill, D. Nochy, J. Andrade, C. Antoine, C. Gautreau, D. Charron, D. Glotz (2008)
Clinical Relevance of Preformed HLA Donor‐Specific Antibodies in Kidney TransplantationAmerican Journal of Transplantation, 8
-
Christopher Wiebe, I. Gibson, T. Blydt-Hansen, D. Pochinco, P. Birk, J. Ho, M. Karpinski, A. Goldberg, L. Storsley, D. Rush, P. Nickerson (2015)
Rates and Determinants of Progression to Graft Failure in Kidney Allograft Recipients With De Novo Donor‐Specific AntibodyAmerican Journal of Transplantation, 15
-
A. Lindholm, S. Henricsson, M. Lind, R. Dahlqvist (2004)
Intraindividual variability in the relative systemic availability of cyclosporin after oral dosingEuropean Journal of Clinical Pharmacology, 34
-
J. Fotheringham, C. Angel, J. Goodwin, A. Harmer, W. Mckane (2011)
Natural History of Proteinuria in Renal Transplant Recipients Developing De Novo Human Leukocyte Antigen AntibodiesTransplantation, 91
-
B. Kahan, M. Welsh, Diana Urbauer, Melinda Mosheim, K. Beusterien, Martha Wood, L. Schoenberg, Joseph Dicesare, Steve Katz, C. Buren (2000)
Low intraindividual variability of cyclosporin A exposure reduces chronic rejection incidence and health care costs.Journal of the American Society of Nephrology : JASN, 11 6
- Publisher
- Unpaywall
- ISSN
- 0085-2538
- DOI
- 10.1016/j.kint.2019.01.033
- Publisher site
- See Article on Publisher Site
Abstract
Journal
Kidney International – Unpaywall
Published: Mar 20, 2019